-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Trevi Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to 2024.
- Trevi Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$10.5 M, a 27.7% decline year-over-year.
- Trevi Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$31.7 M, a 12.5% decline from 2022.
- Trevi Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$28.2 M, a 2.66% increase from 2021.
- Trevi Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$28.9 M, a 0.19% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)